The B12 deficiency that hides behind a normal result
The B12 deficiency that hides behind a normal result
Vitamin B12 deficiency can produce nerve and brain symptoms while a standard serum B12 test still reads inside the reference range. Tingling in the hands or feet, unsteadiness in the dark, word-finding trouble, memory slips and low mood are often the earliest signs, and they can appear well before any change in the full blood count.
The reason is that serum B12 measures total circulating vitamin, and roughly 80 per cent of that total is bound to haptocorrin, a carrier protein your cells cannot use. Only the fraction bound to transcobalamin, measured as holotranscobalamin or "active B12", is actually delivered into tissue. A person can therefore hold a respectable total while the usable portion is running low.
Some of the most common causes are things people are already doing without thinking of them as relevant. Long-term reflux medication is the clearest example: proton pump inhibitors such as esomeprazole, pantoprazole and omeprazole suppress the stomach acid needed to release B12 from food protein, and two or more years of use is associated with a higher risk of deficiency. Long-term metformin carries a similar association.
This matters because of timing. Blood changes reverse once the deficiency is corrected, but prolonged demyelination in the spinal cord and peripheral nerves may not fully recover. Measuring active B12, the fraction your cells can actually take up, gives an earlier and more reliable read than a total level on its own.
What B12 is doing in the nervous system
Vitamin B12 is a cofactor for two enzymes that matter for how you feel day to day. One of them keeps the methylation cycle turning, which builds neurotransmitters and maintains myelin, the insulating sheath around nerve fibres. The other handles a step in fatty acid metabolism that nerve tissue depends on. When either reaction slows the consequences are structural rather than simply energetic: myelin maintenance falters and nerve conduction becomes less efficient.[2] This is why the picture is so often neurological, and why it can look nothing like the anaemia most people expect.
Why a "normal" serum B12 can be misleading
Most laboratories report total serum B12, which sums two very different pools. The larger is bound to haptocorrin and is inert as far as your tissues are concerned. The smaller is bound to transcobalamin, the only portion cells can take up. Because the inert fraction dominates, a result can sit comfortably mid-range while the usable fraction is depleted.[4]
Holotranscobalamin, commonly reported as active B12, measures the usable fraction directly and is regarded as the earliest laboratory parameter to change.[4] Comparative work has generally found it more sensitive than total B12, including in patients presenting with neurological syndromes.[5][6][18] Australian pathology practice already works this way: serum total B12 is the first-line marker, and active B12 is the test called on when a total result lands in an equivocal range and cannot settle the question by itself.[3]
A rarer situation makes the same point in the extreme. In a small group of inherited conditions the body absorbs B12 perfectly well but cannot put it to work inside the cell. Blood levels look entirely normal, sometimes even high, while the person has clear neurological disease.[7] The general lesson holds for everyone: a blood level tells you what is in circulation, not whether your cells are using it.
The symptoms that arrive before the anaemia
The assumption that B12 deficiency announces itself through anaemia is the most common reason it gets missed. Lindenbaum and colleagues examined 141 consecutive patients whose neuropsychiatric problems were attributable to cobalamin deficiency and found that 40 of them, 28 per cent, had no anaemia and no macrocytosis; in 19, both the haematocrit and the mean cell volume were entirely normal. What they did share was markedly elevated methylmalonic acid and homocysteine.[1]
The symptoms in that group remain a useful map: pins and needles, numbness or burning, usually starting in the feet or hands and roughly symmetrical; unsteadiness that worsens in the dark; memory lapses and word-finding difficulty; and mood changes such as depression, irritability or apathy.[1] Fatigue is common but the least specific of them.
Later reviews continue to report cognitive impairment, pins and needles and mood disturbance without the blood signs clinicians are trained to look for.[2][12][19][20] If persistent brain fog or low mood is the presenting problem, B12 belongs in the workup rather than at the end of it. Our brain fog and mood page covers that assessment.
Four markers, four different questions
Each test answers something different. In practice the first two do the work; the second two are specialist tests, listed here so the picture is complete.
| Marker | What it measures | What it tells you |
|---|---|---|
| Serum B12 | Total circulating B12, mostly bound to haptocorrin and unavailable to cells | A late and relatively insensitive signal; can read normal during genuine deficiency |
| Active B12 (holoTC) | The transcobalamin-bound fraction that cells can actually take up | Falls earliest; reflects supply before stores are exhausted |
| Methylmalonic acid | Substrate that accumulates when the mutase reaction stalls | Functional marker; relatively specific to B12 rather than folate |
| Homocysteine | Substrate that accumulates when methionine synthase stalls | Sensitive but also raised by folate or B6 shortfall, thyroid and kidney issues |
Most people do not need the bottom two. MMA and homocysteine are second-line tests reserved for genuinely unclear cases, and homocysteine in particular rises for several reasons that have nothing to do with B12. For the large majority, a total B12 read alongside active B12 and interpreted against symptoms, medications and diet answers the question.
Who tends to be caught out
Absorbing B12 takes several steps. Stomach acid and pepsin release it from food protein, intrinsic factor from gastric parietal cells binds it, and the complex is absorbed in the terminal ileum. Autoimmune damage to parietal cells, the cause of pernicious anaemia, interrupts that chain, as can gastric or ileal surgery and inflammatory bowel disease. Where digestive symptoms sit alongside neurological ones, the gut health, IBS and SIBO picture is worth examining in parallel.
Medications matter more than most people realise, and reflux medication is the one I see most often. A case-control study of 25,956 patients with incident B12 deficiency, against 184,199 without, found two or more years of proton pump inhibitor use associated with increased risk (odds ratio 1.65), a smaller association for H2 blockers (1.25), and a stronger association at higher daily doses.[9] Long-term metformin is the other common contributor.[8][10] Neither is a reason to stop a medication you need; it is a reason to keep an eye on B12 while you take it.
Recreational nitrous oxide behaves differently again, oxidising the cobalt ion at the centre of the cobalamin molecule and disabling methionine synthase regardless of how much B12 is circulating. Case series describe young adults developing spinal cord damage with an unremarkable serum B12.[11][14] Dietary risk is more predictable, since B12 occurs naturally only in animal foods.[2]
Folate is the quieter issue. Because it can restore red cell production independently of B12, a generous folate intake may normalise the blood picture while the neurological process continues unchecked. Studies of older adults report associations between high folate with low B12 and cognitive impairment, though findings across countries have not been consistent.[13][15][16] Anyone on a folate-containing supplement, or carrying a methylation variant, is worth assessing carefully; our MTHFR and methylation page explains how these interact.
Why the window closes
Blood changes correct reliably once the deficiency is addressed. Neurological changes are less forgiving: prolonged demyelination in the spinal cord may leave residual deficits when correction is delayed, and the early-diagnosis literature is explicit that the value of measuring the active fraction lies in intervening before that point.[4][17]
Recovery generally tracks with how long symptoms have been present, so a few months tends to resolve more completely than several years.[1][12] That is the practical argument for testing at the tingling-and-forgetfulness stage. How B12 is replaced, and by which route, depends on the cause and is decided individually.
How we approach it in clinic
Where the history points toward B12, active B12 is the test I want to see rather than a total level on its own, with folate, iron studies and thyroid function in the same panel because their symptoms overlap heavily. A full blood count still earns its place, though a normal one does not close the question. The panels I use are described on the functional testing page.
Interpretation is where the judgement sits, and no single number decides anything. A borderline active B12 in someone on long-term reflux medication, with symmetrical pins and needles and a diet low in animal foods, is a fairly clear picture. The identical number without that context means something quite different. Because unexplained exhaustion is such a common entry point, I assess it alongside the wider picture on our chronic fatigue and burnout page.
Key Insights
Frequently Asked Questions
Can you have a B12 deficiency with a normal blood test?
Yes. Standard testing measures total serum B12, but most of that total is bound to haptocorrin, a carrier protein cells cannot use. Only the transcobalamin-bound portion, reported as active B12, is available to tissue, so the total can sit comfortably within range while the usable fraction is low. That is why symptoms can appear while the result on the page reads normal.
What are the first neurological signs of low B12?
The earliest signs are usually tingling, numbness or burning in the feet or hands, typically fairly symmetrical. Loss of position sense often follows, which shows up as unsteadiness that is worse in the dark or with the eyes closed. Cognitive and mood changes are common too, including memory lapses, word-finding difficulty, irritability and low mood. These can all appear before anaemia develops, which is why they are so often attributed to stress or ageing.
Which B12 test should I ask for?
For most people, active B12 (holotranscobalamin) is the one worth adding. It measures the fraction your cells can actually take up, changes earlier than a total level, and in Australian practice it is the test used when a total B12 result is equivocal. Methylmalonic acid and homocysteine are second-line tests kept for genuinely unclear cases rather than routine use. The more useful question is not which single test to order, but whether the result is being read against your symptoms, medications and diet.
Can nerve damage from B12 deficiency be reversed?
It depends largely on how long it has been present. Blood-related changes correct reliably once the deficiency is addressed. Neurological changes are less predictable: symptoms of a few months' standing tend to resolve more completely than those carried for years, and prolonged spinal cord demyelination may leave lasting deficits. This is the main reason for testing early, when symptoms are still mild, rather than waiting for the picture to become unmistakable.
Does taking folate hide a B12 deficiency?
It can obscure part of it. Folate can support red cell production independently of B12, so a generous folate intake may normalise the blood picture while the neurological process continues underneath. Studies in older adults have examined high folate combined with low B12 status and several report associations with cognitive impairment, though findings have not been consistent across all populations. If you take a folate-containing supplement, B12 status is worth checking properly rather than assuming a normal blood count settles it.
Ready to find answers?
If you have been told your bloods are fine but the tingling, forgetfulness or exhaustion has not shifted, it may be worth looking at what standard testing does not measure.
References
- Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318(26):1720–1728. doi:10.1056/NEJM198806303182604
- Vitamin B12 deficiency and cognitive impairment: a comprehensive review of neurological impact. Brain Disorders. 2025. sciencedirect.com/science/article/pii/S266645932500040X
- Royal College of Pathologists of Australasia. Vitamin B12 and folate testing: use and interpretation. RCPA guideline. rcpa.edu.au/Manuals/RCPA-Manual
- Herrmann W, Obeid R. Causes and early diagnosis of vitamin B12 deficiency. Dtsch Arztebl Int. 2008;105(40):680–685. PMC2696961
- Diagnostic reliability of serum active B12 (holo-transcobalamin) in true evaluation of vitamin B12 deficiency: relevance in current perspective. BMC Res Notes. 2022;15:333. doi:10.1186/s13104-022-06224-8
- Hvas AM, Nexo E. Holotranscobalamin as a predictor of vitamin B12 status. Clin Chem Lab Med. 2003;41(11):1489–1492. PMID:14656030
- A case of vitamin B12 deficiency neurological syndrome in a young adult due to late-onset cobalamin C (CblC) deficiency: a diagnostic challenge. PMC8996322
- Chapman LE, Darling AL, Brown JE. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab. 2016;42(5):316–327. PMID:27130885
- Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435–2442. doi:10.1001/jama.2013.280490
- The effects of daily dose and treatment duration of metformin on the prevalence of vitamin B12 deficiency and peripheral neuropathy in Chinese patients with type 2 diabetes mellitus: a multicentre cross-sectional study. PMC10509512
- Severe subacute combined degeneration of the spinal cord resulting from nitrous oxide (N2O) abuse: a case series. 2025. PMC11823075
- The neurological sequelae of vitamin B12 deficiency: a systematic review and randomized controlled trial. 2025. PMID:40486314
- Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 2007;85(1):193–200. doi:10.1093/ajcn/85.1.193
- Simpson A, et al. Recreational nitrous oxide induced subacute combined degeneration of the spinal cord: a case report. Clin Case Rep. 2023;11(1):e6770. doi:10.1002/ccr3.6770
- Clarke R, Sherliker P, Hin H, et al. Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK. Br J Nutr. 2008;100(5):1054–1059. PMID:18341758
- High folic acid or folate combined with low vitamin B-12 status: potential but inconsistent association with cognitive function in a nationally representative cross-sectional sample of US older adults participating in NHANES. Am J Clin Nutr. 2022. ajcn.nutrition.org
- Cobalamin deficiency: clinical picture and radiological findings. PMC3847746
- Utility of measuring vitamin B12 and its active fraction, holotranscobalamin, in neurological vitamin B12 deficiency syndromes. PMID:20890610
- Assessment of vitamin B12 efficacy on cognitive memory function and depressive symptoms: a systematic review and meta-analysis. PMC11628180
- Assessing the neurological impact of vitamin B12 deficiency among the population of Riyadh, Saudi Arabia. Front Nutr. 2025. doi:10.3389/fnut.2025.1635075
